Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.
Position in QURE — uniQure N.V.
CIK 2011081
WARSZAWA, R9
Position in QURE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$24,028,442
+$15,499,024 QoQ
Shares Held
521,677
0.0% QoQ
Ownership
0.827%
of shares outstanding
% of Portfolio
1.32%
of 13F equity value
Holder Rank
#34
of 254 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QURE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. holds $286,343,836 across 6 Biotechnology names. QURE ranks #4 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
765,332 | $101,988,142 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
479,080 | $89,722,102 | |
| 3 | CYTK |
Cytokinetics Inc
|
660,310 | $56,251,808 | |
| 4 | QURE |
uniQure N.V.
This page
|
521,677 | $24,028,442 | |
| 5 | NKTR |
Nektar Therapeutics
|
122,767 | $8,570,364 | |
| 6 | JANX |
Janux Therapeutics, Inc.
|
376,496 | $5,782,978 |
All Filings in QURE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,028,442 | 521,677 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $8,529,418 | 521,677 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $12,483,730 | 521,677 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $30,450,286 | 521,677 | Shares | Sole | 2025-11-12 | |
| No filing history on record for this holder in this stock. | ||||||